Morgan Stanley analyst Matthew Harrison maintains Adagene (NASDAQ:ADAG) with a Overweight and lowers the price target from $15 to $7.
Alibaba Board Announced That The Company Intends To Spin-off Cainiao By Way Of A Separate Listing Of The Cainiao Shares On The Main Board Of The Hong Kong Stock Exchange
The Board is pleased to announce that the Company intends to spin-off Cainiao by way of a separate listing of the Cainiao Shares on the Main Board of the Hong Kong Stock Exchange. The Company submitted a spin-off
